Departments of Surgery, Washington University, St Louis, MO 63110, USA.
Liver Transpl. 2011 Feb;17(2):189-200. doi: 10.1002/lt.22220.
Hepatic steatosis continues to present a major challenge in liver transplantation. These organs have been shown to have increased susceptibility to cold ischemia/reperfusion (CIR) injury in comparison with otherwise comparable lean livers; the mechanisms governing this increased susceptibility to CIR injury are not fully understood. Endoplasmic reticulum (ER) stress is an important link between hepatic steatosis, insulin resistance, and metabolic syndrome. In this study, we investigated ER stress signaling and blockade in the mediation of CIR injury in severely steatotic rodent allografts. Steatotic allografts from genetically leptin-resistant rodents had increased ER stress responses and increased markers of hepatocellular injury after liver transplantation into strain-matched lean recipients. ER stress response components were reduced by the chemical chaperone taurine-conjugated ursodeoxycholic acid (TUDCA), and this resulted in an improvement in the allograft injury. TUDCA treatment decreased nuclear factor kappa B activation and the proinflammatory cytokines interleukin-6 and interleukin-1β. However, the predominant response was decreased expression of the ER stress cell death mediator [CCAAT/enhancer-binding protein homologous protein (CHOP)]. Furthermore, activation of inflammation-associated caspase-11 was decreased, and this linked ER stress/CHOP to proinflammatory cytokine production after steatotic liver transplantation. These data confirm ER stress in steatotic allografts and implicate this as a mediating mechanism of inflammation and hepatocyte death in the steatotic liver allograft.
肝脂肪变性在肝移植中仍然是一个主要挑战。与其他可比的瘦肝相比,这些器官已被证明对冷缺血/再灌注(CIR)损伤的敏感性增加;但调节这种对 CIR 损伤敏感性增加的机制尚未完全阐明。内质网(ER)应激是肝脂肪变性、胰岛素抵抗和代谢综合征之间的重要联系。在这项研究中,我们研究了 ER 应激信号在严重脂肪变性啮齿动物同种异体移植物 CIR 损伤中的介导作用。来自遗传肥胖抵抗啮齿动物的脂肪变性同种异体移植物在移植到与自身匹配的瘦受体后,表现出 ER 应激反应增加和肝细胞损伤标志物增加。化学伴侣牛磺酸结合熊去氧胆酸(TUDCA)可减少 ER 应激反应成分,从而改善移植物损伤。TUDCA 治疗可降低核因子 kappa B 激活和促炎细胞因子白细胞介素-6 和白细胞介素-1β。然而,主要的反应是 ER 应激细胞死亡介体[CCAAT/增强子结合蛋白同源蛋白(CHOP)]的表达减少。此外,激活的炎症相关半胱天冬酶-11 减少,这将 ER 应激/CHOP 与脂肪变性肝移植后促炎细胞因子的产生联系起来。这些数据证实了脂肪变性同种异体移植物中的 ER 应激,并暗示其作为脂肪变性肝同种异体移植物中炎症和肝细胞死亡的介导机制。